It identified three CRGs (DLD, MTF1, GLS) with differential expression between AD and healthy samples, and four CRGs (LIAS, LIPT1, PDHA1, CDKN2A) with significant expression differences between early-onset and adult-onset AD. This evidence concerns the gene CDKN2A and Alzheimer disease.